|

The Multicenter Stress Cardiac Magnetic Resonance Quantitative Perfusion Imaging in the United States Study

RECRUITINGN/ASponsored by Brigham and Women's Hospital
Actively Recruiting
PhaseN/A
SponsorBrigham and Women's Hospital
Started2025-06-27
Est. completion2029-01
Eligibility
Age35 Years – 85 Years
Healthy vol.Accepted
Locations6 sites

Summary

This research aims to investigate whether symptoms of chest pain or shortness of breath among the study population are arising due to a heart problem, particularly any reduction of blood flow to the heart muscle from blockages in the coronary blood vessels or inflammation of the heart using cardiac magnetic resonance imaging that measures the amount of blood flow during a stress state meant to simulate vigorous exercise. At present, doctors use standard magnetic resonance imaging pictures of blood flow patterns to treat heart disease. The investigators want to study if detailed blood flow measurements, in addition to the standard blood flow pattern, could diagnose heart disease more accurately and allow more doctors to understand the severity of heart disease. Early research has demonstrated that detailed blood flow measurements may be more accurate in diagnosing heart disease in some patients, but doctors need more information to know how to use these measurements.

Eligibility

Age: 35 Years – 85 YearsHealthy volunteers accepted
Inclusion Criteria:

1. male or female at age 35-85 years,
2. presence of either of the following sign/symptom that led to a referral to stress cardiac magnetic resonance imaging:

   1. chest pain or anginal equivalent, or
   2. abnormal electrocardiogram with a suspicion of coronary artery disease
3. Intermediate or high risk of significant coronary disease based on at least 1 of the following conditions:

   a) patient age \> 45 for male, 50 for female b) Diabetes, hypertension, or hypercholesterolemia: by either history or medical treatment c) family history of premature coronary disease: first degree relative at age \<= 55 male and \<=65 female d) history of smoking of \> 10 packed-years e) post-menopausal state \>5 years f) any chronic inflammatory conditions d) Body mass index \> 30 e) Any medical documentation of coronary or peripheral artery disease

Exclusion Criteria:

1. Acute myocardial infarction within the past 30 days prior to cardiac magnetic resonance imaging
2. Confirmed diagnosis of any significant non-coronary cardiac conditions below:

   1. any severe-grade valvular heart disease,
   2. left ventricular ejection fraction \<40% from any known non-coronary causes,
   3. infiltrative cardiomyopathy,
   4. hypertrophic cardiomyopathy,
   5. pericardial disease with significant constriction, or
3. active pregnancy,
4. any competing conditions leading to an expected survival of \< 2 years
5. contraindication to vasodilator (regadenoson or adenosine)
6. metallic device or object that poses an magnetic resonance imaging safety hazard
7. metallic device with a high likelihood of non-diagnostic cardiac magnetic resonance images

Conditions4

Cardiac Magnetic Resonance ImagingHeart DiseaseIschemic Heart Disease (IHD)Myocardial Blood Flow

Locations6 sites

University of California San Francisco
San Francisco, California, 94107
Katie DeSutter559-696-1926Katie.Desutter@ucsf.edu
Brigham and Women's Hospital
Boston, Massachusetts, 02115
Raymond Y Kwong, MD, MPH857-307-1960rykwong@bwh.harvard.edu
Beth Israel Deaconess Medical Center
Boston, Massachusetts, 02215
Connie Tsao, MD, MPH(617) 667-8800ctsao1@bidmc.harvard.edu
Atrium Health - Sanger Heart & Vascular Institute
Charlotte, North Carolina, 28204
Heather Gaines704-468-3201Heather.Gaines@advocatehealth.org
Houston Methodist Hospital
Houston, Texas, 77030
Mariya Potapenko346-238-5103mmpotapenko@houstonmethodist.org

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.